Trial Profile
Study of optimal posology of gonadotrophins in patients with insufficient ovarian response due to age
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 14 Apr 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
- 11 Jan 2008 New trial record.